Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FW30L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,359
Award facts
- Contract value 100% obligated
- $27,358.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,358.58 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, executed on December 5, 2025, represents a firm fixed price delivery order with a completion date of December 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle.
AmerisourceBergen Drug Corp, one of the nation's major pharmaceutical distributors and healthcare solutions providers, has established itself as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This particular delivery order for Ondansetron, an antiemetic medication commonly used in medical settings, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems with essential pharmaceutical inventory through competitive, non-set-aside procurement processes.
Quick answers
Who was awarded contract SPE2DR26FW30L?
SPE2DR26FW30L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FW30L worth?
The government has obligated $27,359 on SPE2DR26FW30L.
Is contract SPE2DR26FW30L an order under another contract?
Yes. SPE2DR26FW30L is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW30L competed?
The extent of competition for SPE2DR26FW30L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award